A notice about cookies

This website uses cookies. Some cookies may have been set already. To find out more about our use of cookies you can visit our Privacy policy. By browsing this website, you agree to our use of cookies.


This is a prototype - your feedback will help us to improve it.


CervicalCheck non-disclosure ex-gratia Scheme Terms of Reference

Published: 3 December 2019
From: Department of Health

The terms of the CervicalCheck non-disclosure ex-gratia Scheme were approved by Government on 11 March 2019, including an Independent Assessment Panel comprising a retired High Court Judge (who will act as Chair), an independent clinician and a person of good standing. The Chair of the Independent Assessment Panel is retired High Court Judge, Aindrias Ó'Caoimh, and the other two members of the Panel are Ms Brigid Doherty and Dr Kevin Connolly.

The role of the panel is to make a determination as to the appropriate amount of the ex- gratia payment, taking into account both the fact of, and impact of, the non-disclosure. Thereafter, it will assess each application against pre-defined criteria to establish whether or not appropriate and timely disclosure took place. Under the terms of scheme, the same amount will be paid to each woman, or her estate, who is assessed by the Panel not to have had appropriate and timely disclosure. All women, or their next of kin, in the 221 cohort identified from the clinical audit as having discordance in their smear test result will be eligible to participate in the Scheme and invitations (on behalf of the Assessment Panel), along with full details of the Scheme, were issued 8 May.

Full details of the Scheme are attached.

Terms of the CervicalCheck non-disclosure ex-gratia scheme for distribution

Terms of the CervicalCheck non-disclosure ex-gratia scheme for distribution


Part of